Cargando…

Dysfunctional Inflammation in Cystic Fibrosis Airways: From Mechanisms to Novel Therapeutic Approaches

Cystic fibrosis (CF) is an inherited disorder caused by mutations in the gene encoding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein, an ATP-gated chloride channel expressed on the apical surface of airway epithelial cells. CFTR absence/dysfunction results in defective i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ghigo, Alessandra, Prono, Giulia, Riccardi, Elisa, De Rose, Virginia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7920244/ https://www.ncbi.nlm.nih.gov/pubmed/33669352 http://dx.doi.org/10.3390/ijms22041952

Ejemplares similares

Airway Epithelium Dysfunction in Cystic Fibrosis and COPD
por: De Rose, Virginia, et al.
Publicado: (2018)

New Developments in Cystic Fibrosis Airway Inflammation
por: Palaniyar, Nades, et al.
Publicado: (2015)

IRE1α Is a Therapeutic Target for Cystic Fibrosis Airway Inflammation
por: Hull-Ryde, Emily A., et al.
Publicado: (2021)

Airway Inflammatory/Immune Responses in COPD and Cystic Fibrosis
por: De Rose, Virginia, et al.
Publicado: (2018)

Inhaled Biologicals for the Treatment of Cystic Fibrosis
por: Sala, Valentina, et al.
Publicado: (2019)

Infection and Inflammation MUC up the Cystic Fibrosis Airway
por: Ma, Jonathan
Publicado: (2022)

Inflammation and Airway Microbiota during Cystic Fibrosis Pulmonary Exacerbations
por: Zemanick, Edith T., et al.
Publicado: (2013)

Role of Protein Kinase A-Mediated Phosphorylation in CFTR Channel Activity Regulation
por: Della Sala, Angela, et al.
Publicado: (2021)

Novel therapeutic approaches for the management of cystic fibrosis
por: Jaques, Ryan, et al.
Publicado: (2020)

The Resolution Approach to Cystic Fibrosis Inflammation
por: Recchiuti, Antonio, et al.
Publicado: (2020)

Approaches to Targeting Bacterial Biofilms in Cystic Fibrosis Airways
por: Martin, Isaac, et al.
Publicado: (2021)

CFTR Modulator Therapies: Potential Impact on Airway Infections in Cystic Fibrosis
por: Saluzzo, Francesca, et al.
Publicado: (2022)

Furin as a therapeutic target in cystic fibrosis airways disease
por: Douglas, Lisa E.J., et al.
Publicado: (2023)

Antiproteases as Therapeutics to Target Inflammation in Cystic Fibrosis
por: Quinn, Derek J, et al.
Publicado: (2010)

Metabolic Modeling of Cystic Fibrosis Airway Communities Predicts Mechanisms of Pathogen Dominance
por: Henson, Michael A., et al.
Publicado: (2019)

Letting It All Out: Neutrophils in Early Cystic Fibrosis Airway Inflammation
por: Perrem, Lucy, et al.
Publicado: (2019)

Moving the Dial on Airway Inflammation in Response to Trikafta in Adolescents with Cystic Fibrosis
por: Lepissier, Agathe, et al.
Publicado: (2023)

The fungal airway microbiome in cystic fibrosis and non-cystic fibrosis bronchiectasis
por: Cuthbertson, Leah, et al.
Publicado: (2021)

Burkholderia cenocepacia Infections in Cystic Fibrosis Patients: Drug Resistance and Therapeutic Approaches
por: Scoffone, Viola C., et al.
Publicado: (2017)

Mechanical insufflation–exsufflation for airway clearance in adults with cystic fibrosis
por: Gaynor, Madeline, et al.
Publicado: (2018)

Role of IRE1α/XBP-1 in Cystic Fibrosis Airway Inflammation
por: Ribeiro, Carla M. P., et al.
Publicado: (2017)

Inflammation as a Regulator of the Airway Surface Liquid pH in Cystic Fibrosis
por: Rehman, Tayyab, et al.
Publicado: (2023)

Airway inflammatory markers in individuals with cystic fibrosis and non-cystic fibrosis bronchiectasis
por: Bergin, David A, et al.
Publicado: (2013)

Inflammation in Cystic Fibrosis
Publicado: (1996)

Cell-Based Therapeutic Approaches for Cystic Fibrosis
por: Duchesneau, Pascal, et al.
Publicado: (2020)

Editorial: Emerging Therapeutic Approaches for Cystic Fibrosis
por: Lopes-Pacheco, Miquéias, et al.
Publicado: (2019)

3123 TGFbeta, Early Cytokine Dysregulation, and Airway Smooth Muscle Dysfunction in Cystic Fibrosis
por: Kramer, Elizabeth L, et al.
Publicado: (2019)

Genetic Deletion and Pharmacological Inhibition of PI3Kγ Reduces Neutrophilic Airway Inflammation and Lung Damage in Mice with Cystic Fibrosis-Like Lung Disease
por: Galluzzo, Maria, et al.
Publicado: (2015)

Therapeutic interventions alter ecological interactions among cystic fibrosis airway microbiota
por: Ho, Pok-Man, et al.
Publicado: (2023)

Commensal Bacteria in the Cystic Fibrosis Airway Microbiome Reduce P. aeruginosa Induced Inflammation
por: Tony-Odigie, Andrew, et al.
Publicado: (2022)

Toothbrushes may convey bacteria to the cystic fibrosis lower airways
por: Passarelli Mantovani, Rebeca, et al.
Publicado: (2019)

The cystic fibrosis lower airways microbial metagenome
por: Moran Losada, Patricia, et al.
Publicado: (2016)

The Cystic Fibrosis Upper and Lower Airway Metagenome
por: Pienkowska, Katarzyna, et al.
Publicado: (2023)

Modulator Combination Improves In Vitro the Microrheological Properties of the Airway Surface Liquid of Cystic Fibrosis Airway Epithelia
por: Ludovico, Alessandra, et al.
Publicado: (2022)

Emerging microRNA Therapeutic Approaches for Cystic Fibrosis
por: Bardin, Pauline, et al.
Publicado: (2018)

Cystic fibrosis: current therapeutic targets and future approaches
por: Rafeeq, Misbahuddin M., et al.
Publicado: (2017)

Editorial: Special Issue on “Therapeutic Approaches for Cystic Fibrosis”
por: Pedemonte, Nicoletta
Publicado: (2020)

Cystic Fibrosis Bone Disease: The Interplay between CFTR Dysfunction and Chronic Inflammation
por: Fonseca, Óscar, et al.
Publicado: (2023)

Roles, Actions, and Therapeutic Potential of Specialized Pro-resolving Lipid Mediators for the Treatment of Inflammation in Cystic Fibrosis
por: Recchiuti, Antonio, et al.
Publicado: (2019)

Upper versus lower airway microbiome and metagenome in children with cystic fibrosis and their correlation with lung inflammation
por: Kirst, Mariana E., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_1bjmediqdlikaadlmf79q2o59u